Sivik Global Healthcare LLC Gilead Sciences, Inc. Transaction History

Sivik Global Healthcare LLC

  • $236 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 13, 2020
SELL
$62.1 - $78.08 $3.11 Million - $3.9 Million
-50,000 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$72.34 - $84.0 $3.62 Million - $4.2 Million
50,000 New
50,000 $3.85 Million
Q4 2017

Feb 08, 2018
SELL
$71.15 - $83.52 $5.69 Million - $6.68 Million
-80,000 Closed
0 $0
Q3 2017

Nov 08, 2017
BUY
$72.11 - $85.47 $5.77 Million - $6.84 Million
80,000
80,000 $6.48 Million

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Sivik Global Healthcare LLC Portfolio

Follow Sivik Global Healthcare LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sivik Global Healthcare LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sivik Global Healthcare LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email